Research Article

Mineralocorticoid Receptor Antagonist Treatment for Steroid-Induced Central Serous Chorioretinopathy Patients with Continuous Systemic Steroid Treatment

Figure 4

Best-corrected visual acuity (BCVA) changes after spironolactone treatment. LogMAR BCVA was significantly improved after spironolactone treatment (before, 0.280 ± 0.068; after, 0.146 ± 0.035, ).